Form 4 for NTRA Natera, Inc.
Accepted 2024-10-03 00:00:00 ET · period of report 2024-10-01 · accession 0001415889-24-024709 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-10-03 | 2024-10-01 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $125.60 | -2,700 | 282.0K | -0.9% | -$339.1K |
| MI | 2024-10-03 | 2024-10-01 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $125.67 | -3,000 | 58.5K | -5% | -$377.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-01 | S | D | 876 | $124.82 | 283,865 | D | — | — | (F1) The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023. (F2) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.27 to $125.17 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2024-10-01 | S | D | 1,397 | $125.83 | 282,468 | D | — | — | (F1) The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023. (F3) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.32 to $126.30 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2024-10-01 | S | D | 427 | $126.42 | 282,041 | D | — | — | (F1) The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023. (F4) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.33 to $126.5050 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 4 | Common | Common Stock | 2024-10-01 | S | D | 1,025 | $125.95 | 57,432 | I By Caraluna 2 Trust | — | — | (F5) The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023. (F10) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.3850 to $126.3050 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F7) Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities. |
| 5 | Common | Common Stock | 2024-10-01 | S | D | 771 | $125.23 | 58,161 | I By Caraluna 1 Trust | — | — | (F5) The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023. (F6) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.78 to $125.53 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F7) Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities. |
| 6 | Common | Common Stock | 2024-10-01 | S | D | 729 | $126.27 | 57,432 | I By Caraluna 1 Trust | — | — | (F5) The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023. (F8) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.78 to $126.5050 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F7) Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities. |
| 7 | Common | Common Stock | 2024-10-01 | S | D | 475 | $124.89 | 58,457 | I By Caraluna 2 Trust | — | — | (F5) The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023. (F9) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.35 to $125.18 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F7) Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities. |